Aemetis Q4 EPS Beats, Revenue Misses by 37.6%, Shares Up 21.1%
Aemetis reported a Q4 adjusted loss of $0.24 per share on $43.3M revenue, beating EPS estimates by 11.11% but falling 37.6% short of consensus. Loop Capital set a $1.75 price target, implying 2.04% upside as shares have risen 21.1% reflecting market volatility.
1. Q4 Financial Results
Aemetis reported a fourth-quarter adjusted net loss of $0.24 per share on revenues of $43.3 million, exceeding EPS expectations by 11.11% but undershooting revenue forecasts by 37.6%. GAAP net loss was $5.3 million, or $0.08 per share, reflecting operational pressures.
2. Full-Year Performance
For the full 2025 fiscal year, the company posted a net loss of $77 million, or $1.28 per share, on total revenue of $197.6 million. Both earnings and sales declined year-over-year, underscoring challenges in scaling its biofuels and specialty chemicals operations.
3. Price Target and Market Reaction
Loop Capital assigned a $1.75 price target, suggesting roughly 2.04% upside from recent levels. Shares have jumped 21.1%, trading intraday between $1.49 and $1.88 with a 52-week range of $1.22 to $3.66, indicating heightened volatility.
4. Revenue Challenges and Outlook
Aemetis has missed revenue estimates for four consecutive quarters, raising concerns about demand and production capacity. With a market cap near $123.5 million and average daily volume above 2 million shares, investors will monitor contract ramp-ups and cost control for signs of sustainable growth.